ARCHIVES

Sponsors Withdraw Indications for Iressa, Celebrex

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

Berlin, DeVita Differ On Use Of L-PAM

November 8, 1974

Roswell Park Celebrates 50th Anniversary of Pivotal Congressional Visit

October 20, 2021

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Harkin, Hatfield Introduce Medical Research Trust Fund

March 4, 1994

Newcomers Undercut Price of BRCA Test; Myriad Lawsuits Claim Patent Infringement

July 25, 2013